Drug Trial Radar · NCT07215559
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Oct 16, 2025
Primary completion
Mar 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Oct 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate weight reduction with macupatide and eloralintide, alone or in combination, in adult participants with obesity or overweight and with type 2 diabetes. Participation in the study will last about 48 weeks.
Conditions
- Obesity
- Overweight
- Diabetes Mellitus, Type 2
Interventions
MacupatideDrug
Administered SC
EloralintideDrug
Administered SC
Macupatide PlaceboDrug
Administered SC
Eloralintide PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change from Baseline in Body WeightTime frame: Baseline, Week 32
Locations
42 sites in 4 countries. Site status is shown where the registry gives one.
Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC
Gilbert, Arizona
Synexus Clinical Research US, Inc.
Phoenix, Arizona
Pima Heart
Tucson, Arizona
Precision Clinical Research
Sunrise, Florida
SKY Clinical Research Network Group-Brown
Atlanta, Georgia
Teak Research Consults
Lawrenceville, Georgia
AGILE Clinical Research Trials, LLC
Sandy Springs, Georgia
Pivotal Research Solutions
Stonecrest, Georgia
Rophe Adult and Pediatric Medicine/SKYCRNG
Union City, Georgia
Vector Clinical Trials
Las Vegas, Nevada
Premier Research
Trenton, New Jersey
PriMED Clinical Research
Dayton, Ohio
Mercy Family Clinic
Dallas, Texas
Velocity Clinical Research, Dallas
Dallas, Texas
Biopharma Informatic, LLC
Houston, Texas
PlanIt Research, PLLC
Houston, Texas
Research Physicians Network, LLC
Houston, Texas
Aavon Clinical Trials
Richmond, Texas
Consano Clinical Research, LLC
Shavano Park, Texas
Texas Valley Clinical Research
Weslaco, Texas
Kalo Clinical Research
West Valley City, Utah
Eastern Virginia Medical School (EVMS) Medical Group
Norfolk, Virginia
Clinical Research Partners, LLC
Richmond, Virginia
Northwest Clinical Research Center
Bellevue, Washington
Rainier Clinical Research Center
Renton, Washington
Universal Research Group
Tacoma, Washington
Centro de Investigaciones Metabólicas (CINME)
Buenos Aires, Argentina
CENUDIAB
Buenos Aires, Argentina
CEDIC
CABA, Argentina
Instituto de Investigaciones Clínicas Córdoba
Córdoba, Argentina
Clínica Universitaria Reina Fabiola
Córdoba, Argentina
Go Centro Medico San Nicolás
San Nicolás, Argentina
Emeritus Research
Botany, Australia
Core Research Group
Brisbane, Australia
Emeritus Research
Camberwell, Australia
Cornerstone Dermatology
Coorparoo, Australia
Momentum Darlinghurst
Darlinghurst, Sydney, Australia
CDH Research Institute Pty Ltd
Maroochydore, Australia
Momentum Sunshine
Melbourne, Australia
AIM Research
Merewether, Australia
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.